Literature DB >> 1974826

Immunosuppression in murine renal cell carcinoma. II. Identification of responsible lymphoid cell phenotypes and examination of elimination of suppression.

S K Gregorian1, J R Battisto.   

Abstract

In our companion paper we have reported that cell-mediated immunity of mice bearing renal cell carcinoma is profoundly suppressed. The non-responsiveness of such animals was found to be attributable to Renca cells themselves and to splenic lymphoid cells that down-regulate other fully capable lymphoid cells. In this communication the lymphoid cell source of suppression within Renca-bearing mice has been explored with the aim of identifying phenotypes of the responsible cells, the manner by which suppression is mediated, and initial ways by which suppression may be eliminated. A plastic-adherent cell bearing the Thy1.2 surface marker as well as the Lyt1 and Lyt2 antigens has been found to operate, perhaps in conjunction with macrophages, to down-regulate lymphokine-activated killer (LAK) cell development for natural killer (NK) and non-NK targets that include Renca cells themselves. The splenic suppressor cells lost the capacity to suppress the NK response of normal recipient mice upon shallow irradiation (250 rad) prior to adoptive transfer. Spleen cells, presumably macrophages, from Renca-bearing mice were found to suppress the generation of LAK and NK cells in vitro by synthesizing prostaglandins. Indomethacin, a prostaglandin synthetase inhibitor, blocked the induction of suppression both in vitro and in vivo, suggesting the presence of endogenous prostaglandins in Renca-bearing mice. The suppression seen in Renca-bearing mice that derives from multiple sources and has been prevented by two separate methods has been discussed from the viewpoint of the inter-relatedness of the sources.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1974826     DOI: 10.1007/bf01741404

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  44 in total

1.  Suppression of T cell-mediated immunity by tumor cells: immunogenicity versus immunosuppression and preliminary characterization of the suppressive factors.

Authors:  C C Ting; D Rodrigues; R C Ting; N Wivel; M J Collins
Journal:  Int J Cancer       Date:  1979-11-15       Impact factor: 7.396

Review 2.  Suppressor cells: permitters and promoters of malignancy?

Authors:  D Naor
Journal:  Adv Cancer Res       Date:  1979       Impact factor: 6.242

3.  Enhancement of tumor growth in mice: evidence for the involvement of host macrophages.

Authors:  S A Kadhim; R C Rees
Journal:  Cell Immunol       Date:  1984-08       Impact factor: 4.868

4.  Immunosuppression in murine renal cell carcinoma. I. Characterization of extent, severity and sources.

Authors:  S K Gregorian; J R Battisto
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

Review 5.  Suppressor T cells and the immune response to tumors.

Authors:  S Schatten; R D Granstein; J A Drebin; M I Greene
Journal:  Crit Rev Immunol       Date:  1984       Impact factor: 2.214

6.  Suppression of T lymphocyte proliferation during lymphoma growth in mice: role of PGE2-producing suppressor macrophages.

Authors:  D Gemsa; H G Leser; W Deimann; K Resch
Journal:  Immunobiology       Date:  1982-04       Impact factor: 3.144

7.  Changes in the host natural killer cell population in mice during tumor development. 1. Kinetics and in vivo significance.

Authors:  P K Lala; V Santer; H Libenson; R S Parhar
Journal:  Cell Immunol       Date:  1985-07       Impact factor: 4.868

8.  Changes in the host natural killer cell population in mice during tumor development. 2. The mechanism of suppression of NK activity.

Authors:  R S Parhar; P K Lala
Journal:  Cell Immunol       Date:  1985-07       Impact factor: 4.868

9.  Flavone-8-acetic acid augments systemic natural killer cell activity and synergizes with IL-2 for treatment of murine renal cancer.

Authors:  R H Wiltrout; M R Boyd; T C Back; R R Salup; J A Arthur; R L Hornung
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

10.  T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases.

Authors:  E S Dye; R J North
Journal:  J Exp Med       Date:  1981-10-01       Impact factor: 14.307

View more
  2 in total

1.  Immunosuppression in murine renal cell carcinoma. I. Characterization of extent, severity and sources.

Authors:  S K Gregorian; J R Battisto
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

2.  Growth of MCF-7 human breast carcinoma in severe combined immunodeficient mice: growth suppression by recombinant interleukin-2 treatment and role of lymphokine-activated killer cells.

Authors:  Y F Zhai; W J Esselman; C S Oakley; C C Chang; C W Welsch
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.